Skip to content
10-Q

Quarterly Report

BETA BIONICS, INC. BBNX

0000950170-25-064504

← back to feed
Filed
May 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Apr 30, 2025 43.36M sh
Short Term Investments Q1 2025 · Mar 31, 2025 $189.02M
Short Term Investments Q1 2025 · Dec 31, 2024 $73.14M
Current Liabilities Q1 2025 · Mar 31, 2025 $16.49M
Current Liabilities Q1 2025 · Dec 31, 2024 $21.15M
Total Liabilities Q1 2025 · Mar 31, 2025 $24.27M
Total Liabilities Q1 2025 · Dec 31, 2024 $73.63M
Current Assets Q1 2025 · Mar 31, 2025 $261.92M
Current Assets Q1 2025 · Dec 31, 2024 $132.92M
Total Assets Q1 2025 · Mar 31, 2025 $338.02M
Total Assets Q1 2025 · Dec 31, 2024 $149.65M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $30.43M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $22.07M
Shares Diluted Q1 2025 · Mar 31, 2024 6.02M sh
Capex Q1 2025 · Mar 31, 2024 $406K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$12.14M
Stockholders Equity Q1 2025 · Mar 31, 2024 −$214.32M
Stockholders Equity Q1 2025 · Dec 31, 2023 −$203.11M
Eps Diluted Q1 2025 · Mar 31, 2024 −$2.07
Eps Basic Q1 2025 · Mar 31, 2024 −$2.07
Sga Expense Q1 2025 · Mar 31, 2024 $3.51M
Rd Expense Q1 2025 · Mar 31, 2024 $5.48M
Net Income Q1 2025 · Mar 31, 2024 −$12.45M
Operating Income Q1 2025 · Mar 31, 2024 −$9.45M
Gross Profit Q1 2025 · Mar 31, 2024 $7.2M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $5.73M
Revenue Q1 2025 · Mar 31, 2024 $12.93M